Tokyo Center Clinic

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials
• Mild cognitive impairment2 trials
• Chronic kidney disease1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials

Status

• Completed3 trials

Lead sponsor

• Novo Nordisk A/S3 trials

Closed trials

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

  NCT03819153· Phase 3· Novo Nordisk A/S· Source